Sinopharm Group (Germany) Market Value
| X2S Stock | EUR 2.64 0.04 1.54% |
| Symbol | Sinopharm |
Sinopharm Group 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sinopharm Group's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sinopharm Group.
| 11/22/2024 |
| 12/22/2024 |
If you would invest 0.00 in Sinopharm Group on November 22, 2024 and sell it all today you would earn a total of 0.00 from holding Sinopharm Group Co or generate 0.0% return on investment in Sinopharm Group over 30 days. Sinopharm Group is related to or competes with AmerisourceBergen, Cardinal Health, Henry Schein, Shanghai Pharmaceuticals, SINOPHARM GROUP, and Prestige Consumer. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and heal... More
Sinopharm Group Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sinopharm Group's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sinopharm Group Co upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.95 | |||
| Information Ratio | 0.1721 | |||
| Maximum Drawdown | 18.93 | |||
| Value At Risk | (3.20) | |||
| Potential Upside | 4.47 |
Sinopharm Group Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sinopharm Group's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sinopharm Group's standard deviation. In reality, there are many statistical measures that can use Sinopharm Group historical prices to predict the future Sinopharm Group's volatility.| Risk Adjusted Performance | 0.1528 | |||
| Jensen Alpha | 0.4698 | |||
| Total Risk Alpha | 0.4105 | |||
| Sortino Ratio | 0.1571 | |||
| Treynor Ratio | 0.6685 |
Sinopharm Group Backtested Returns
Sinopharm Group appears to be relatively risky, given 3 months investment horizon. Sinopharm Group owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.18, which indicates the firm had a 0.18% return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Sinopharm Group Co, which you can use to evaluate the volatility of the company. Please review Sinopharm Group's Semi Deviation of 2.27, risk adjusted performance of 0.1528, and Coefficient Of Variation of 543.45 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Sinopharm Group holds a performance score of 14. The entity has a beta of 0.73, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Sinopharm Group's returns are expected to increase less than the market. However, during the bear market, the loss of holding Sinopharm Group is expected to be smaller as well. Please check Sinopharm Group's potential upside, skewness, and the relationship between the maximum drawdown and semi variance , to make a quick decision on whether Sinopharm Group's existing price patterns will revert.
Auto-correlation | 0.12 |
Insignificant predictability
Sinopharm Group Co has insignificant predictability. Overlapping area represents the amount of predictability between Sinopharm Group time series from 22nd of November 2024 to 7th of December 2024 and 7th of December 2024 to 22nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sinopharm Group price movement. The serial correlation of 0.12 indicates that less than 12.0% of current Sinopharm Group price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.12 | |
| Spearman Rank Test | -0.08 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Sinopharm Group lagged returns against current returns
Autocorrelation, which is Sinopharm Group stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Sinopharm Group's stock expected returns. We can calculate the autocorrelation of Sinopharm Group returns to help us make a trade decision. For example, suppose you find that Sinopharm Group has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Sinopharm Group regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Sinopharm Group stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Sinopharm Group stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Sinopharm Group stock over time.
Current vs Lagged Prices |
| Timeline |
Sinopharm Group Lagged Returns
When evaluating Sinopharm Group's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Sinopharm Group stock have on its future price. Sinopharm Group autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Sinopharm Group autocorrelation shows the relationship between Sinopharm Group stock current value and its past values and can show if there is a momentum factor associated with investing in Sinopharm Group Co.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Sinopharm Stock
Sinopharm Group financial ratios help investors to determine whether Sinopharm Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sinopharm with respect to the benefits of owning Sinopharm Group security.